Literature DB >> 11310856

Regulation of L-selectin expression by a dominant negative Ikaros protein.

I Christopherson1, M Piechoki, G Liu, S Ratner, A Galy.   

Abstract

Ikaros family members play critical roles in hematopoietic development, yet molecules regulated by Ikaros proteins remain incompletely characterized. To determine the requirements for functional Ikaros proteins, we overexpressed Ik7, a dominant negative Ikaros protein, in human cell lines and hematopoietic progenitor cells. Ik7 is known to block the normal function of other Ikaros family members in human and mouse cells. Retroviral-mediated overexpression of Ik7 affected two distinct, migratory properties of the CEM T-cell line. Ik7 down-regulated L-selectin cell-surface expression, an effect not a result of increased shedding but of a decrease in L-selectin mRNA levels. Ik7 also reduced the spontaneous migration of CEM T cells in 3-D collagen gels. A reduction in L-selectin, cell-surface expression was also induced by Ik7 in CD34+ hematopoietic progenitor cells. In contrast, the Reh B cell line showed an up-regulation of L-selectin, cell-surface levels when expressing Ik7. For the first time, this study defines an effect of Ikaros proteins in the control of migration-related properties and shows that intact Ikaros proteins are important in a cell type-specific manner for the normal regulation of L-selectin expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310856

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  Lack of Ikaros cripples expression of Foxo1 and its targets in naive T cells.

Authors:  Parul Agnihotri; Nicholas M Robertson; Sarah E Umetsu; Ksenia Arakcheeva; Susan Winandy
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

2.  Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.

Authors:  Shereen Ezzat; Shunjiang Yu; Sylvia L Asa
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.